Last reviewed 2026-04-23 · How we verify

stable HAART

Stable HAART refers to a long-term antiretroviral therapy regimen that maintains viral suppression in HIV-1 infected patients.

Stable HAART refers to a long-term antiretroviral therapy regimen that maintains viral suppression in HIV-1 infected patients. Used for Treatment of HIV-1 infection.

At a glance

Mechanism of action

Stable HAART involves the combination of multiple antiretroviral drugs to suppress HIV-1 replication, thereby preventing the progression of the disease. This approach aims to maintain viral loads below detectable levels, reducing the risk of transmission and complications associated with HIV-1 infection.

Approved indications

• Treatment of HIV-1 infection

Common side effects

• Nausea
• Diarrhea
• Fatigue

Key clinical trials

• To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults (PHASE3)
• Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy (PHASE1)
• HIV Fat Redistribution and the Evaluation of Brown Fat
• A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation
• Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV (PHASE1)
• The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (PHASE3)
• Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels (PHASE2)
• Treatment De-Intensification and Residual HIV-1 in Youth

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.